Jon S. Kuwahara
Keine laufenden Positionen mehr
Karriereverlauf von Jon S. Kuwahara
Ehemalige bekannte Positionen von Jon S. Kuwahara
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ELEDON PHARMACEUTICALS, INC. | Verwaltungsdirektor | 15.03.2021 | 31.07.2021 |
Comptroller/Controller/Auditor | 09.09.2020 | 31.07.2021 | |
Vorstandsvorsitzender | 04.09.2020 | 09.09.2020 | |
Finanzdirektor/CFO | 10.07.2017 | 15.03.2021 | |
Espero Pharmaceuticals, Inc.
Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Espero Pharmaceuticals, Inc. is a pharmaceutical company that specializes in developing therapeutics for unmet needs in thrombosis and cardiac rhythm control. Espero Pharmaceuticals is based in Jacksonville, FL and has subsidiaries in the United States. The private company's portfolio includes tecarfarin, which is used for patients requiring anticoagulation, and a novel candidate for treating arrhythmias. The company was founded by Jeffrey S. Cole and Quang X. Pham. | Corporate Officer/Principal | 01.06.2016 | 01.06.2017 |
AVANIR PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 01.11.2014 | 01.06.2016 |
QUESTCOR PHARMACEUTICALS INC | Corporate Officer/Principal | 01.10.2010 | 01.10.2014 |
EMMAUS LIFE SCIENCES, INC. | Direktor/Vorstandsmitglied | - | - |
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Direktor/Vorstandsmitglied | 16.12.2015 | - |
Ausbildung von Jon S. Kuwahara
University of Hawai'i at Hilo | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
Director/Board Member | 2 |
Comptroller/Controller/Auditor | 2 |
Corporate Officer/Principal | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 2 |
Distribution Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ELEDON PHARMACEUTICALS, INC. | Health Technology |
EMMAUS LIFE SCIENCES, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
EMI Holding, Inc.
EMI Holding, Inc. Pharmaceuticals: MajorHealth Technology EMI Holding, Inc. discovers, develops, and commercializes treatments and therapies for rare diseases. The firm also engages in the marketing and sale of NutreStore L-glutamine powder for oral solution, a treatment for short bowel syndrome and the sale of L-glutamine as a nutritional supplement under the brand name AminoPure. The company was founded by Yutaka Niihara in 1987 and is headquartered in Torrance, CA. | Health Technology |
Espero Pharmaceuticals, Inc.
Espero Pharmaceuticals, Inc. Medical DistributorsDistribution Services Espero Pharmaceuticals, Inc. is a pharmaceutical company that specializes in developing therapeutics for unmet needs in thrombosis and cardiac rhythm control. Espero Pharmaceuticals is based in Jacksonville, FL and has subsidiaries in the United States. The private company's portfolio includes tecarfarin, which is used for patients requiring anticoagulation, and a novel candidate for treating arrhythmias. The company was founded by Jeffrey S. Cole and Quang X. Pham. | Distribution Services |
Avanir Pharmaceuticals, Inc.
Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
- Börse
- Insiders
- Jon S. Kuwahara
- Erfahrung